ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,700 | +40.9% | 19,800 | +49.3% | 0.00% | – |
| Q2 2023 | $21,080 | +110847.4% | 13,258 | -50.4% | 0.00% | – |
| Q1 2023 | $19 | +18.8% | 26,737 | -3.3% | 0.00% | – |
| Q4 2022 | $16 | -99.9% | 27,657 | -10.9% | 0.00% | – |
| Q3 2022 | $30,000 | +130.8% | 31,028 | +190.0% | 0.00% | – |
| Q2 2022 | $13,000 | -27.8% | 10,700 | -20.1% | 0.00% | – |
| Q1 2022 | $18,000 | -68.4% | 13,400 | -57.7% | 0.00% | – |
| Q4 2021 | $57,000 | -26.0% | 31,700 | -8.9% | 0.00% | – |
| Q3 2021 | $77,000 | -34.7% | 34,800 | +3.9% | 0.00% | – |
| Q2 2021 | $118,000 | – | 33,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
| Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
| ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
| RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
| Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
| VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
| Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
| VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
| Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |